182 related articles for article (PubMed ID: 21209397)
21. The Effect of Low Doses of Acetylsalicylic Acid on the Occurrence of Rectal Aberrant Crypt Foci.
Kowalczyk M; Sigorski D; Dyśko Ł; Zieliński E; Zupanovich Lucka D; Klepacki Ł
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556972
[TBL] [Abstract][Full Text] [Related]
22. Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial.
Higurashi T; Ashikari K; Tamura S; Saigusa Y; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Kessoku T; Hosono K; Yoneda M; Nakajima A
Cancer Prev Res (Phila); 2022 Oct; 15(10):661-668. PubMed ID: 36083855
[TBL] [Abstract][Full Text] [Related]
23. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.
Feldman HH; Doody RS; Kivipelto M; Sparks DL; Waters DD; Jones RW; Schwam E; Schindler R; Hey-Hadavi J; DeMicco DA; Breazna A;
Neurology; 2010 Mar; 74(12):956-64. PubMed ID: 20200346
[TBL] [Abstract][Full Text] [Related]
24. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
26. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
Pedersen TR; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Holme I; Larsen ML; Bendiksen FS; Lindahl C; Szarek M; Tsai J;
JAMA; 2005 Nov; 294(19):2437-45. PubMed ID: 16287954
[TBL] [Abstract][Full Text] [Related]
27. Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women.
Berthold HK; Unverdorben S; Zittermann A; Degenhardt R; Baumeister B; Unverdorben M; Krone W; Vetter H; Gouni-Berthold I
Osteoporos Int; 2004 Jun; 15(6):459-67. PubMed ID: 15205717
[TBL] [Abstract][Full Text] [Related]
28. Effects of dietary wheat bran fiber on rectal epithelial cell proliferation in patients with resection for colorectal cancers.
Alberts DS; Einspahr J; Rees-McGee S; Ramanujam P; Buller MK; Clark L; Ritenbaugh C; Atwood J; Pethigal P; Earnest D
J Natl Cancer Inst; 1990 Aug; 82(15):1280-5. PubMed ID: 2165179
[TBL] [Abstract][Full Text] [Related]
29. STAR VaS--Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery.
Neilipovitz DT; Bryson GL; Taljaard M
Can J Anaesth; 2012 Jun; 59(6):527-37. PubMed ID: 22528165
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia. Collaborative Atorvastatin Study Group.
McKenney JM; McCormick LS; Weiss S; Koren M; Kafonek S; Black DM
Am J Med; 1998 Feb; 104(2):137-43. PubMed ID: 9528731
[TBL] [Abstract][Full Text] [Related]
31. Effect of dietary fibre of barley variety 'Rihane' on azoxymethane-induced aberrant crypt foci development and on colonic microbiota diversity in rats.
Lahouar L; Pochart P; Salem HB; El Felah M; Mokni M; Magne F; Mangin I; Suau A; Pereira E; Hammami M; Achour L
Br J Nutr; 2012 Dec; 108(11):2034-42. PubMed ID: 22414704
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial.
Suleiman M; Koestler C; Lerman A; Lopez-Jimenez F; Herges R; Hodge D; Bradley D; Cha YM; Brady PA; Munger TM; Asirvatham SJ; Packer DL; Friedman PA
Heart Rhythm; 2012 Feb; 9(2):172-8. PubMed ID: 21920481
[TBL] [Abstract][Full Text] [Related]
33. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness.
Taylor AJ; Kent SM; Flaherty PJ; Coyle LC; Markwood TT; Vernalis MN
Circulation; 2002 Oct; 106(16):2055-60. PubMed ID: 12379573
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome.
Arca M
Drugs; 2007; 67 Suppl 1():43-54. PubMed ID: 17910520
[TBL] [Abstract][Full Text] [Related]
35. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.
Kruger P; Bailey M; Bellomo R; Cooper DJ; Harward M; Higgins A; Howe B; Jones D; Joyce C; Kostner K; McNeil J; Nichol A; Roberts MS; Syres G; Venkatesh B;
Am J Respir Crit Care Med; 2013 Apr; 187(7):743-50. PubMed ID: 23348980
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
Sever PS; Poulter NR; Dahlof B; Wedel H;
J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
[TBL] [Abstract][Full Text] [Related]
37. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery.
Prowle JR; Calzavacca P; Licari E; Ligabo EV; Echeverri JE; Haase M; Haase-Fielitz A; Bagshaw SM; Devarajan P; Bellomo R
Nephrology (Carlton); 2012 Mar; 17(3):215-24. PubMed ID: 22117606
[TBL] [Abstract][Full Text] [Related]
38. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR; Leslie S; Stern T;
JAMA; 2001 Apr; 285(13):1711-8. PubMed ID: 11277825
[TBL] [Abstract][Full Text] [Related]
39. Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): response to Server et al.
Tseng KH
Diabetes Care; 2005 Oct; 28(10):2595; author reply 2595-6. PubMed ID: 16186315
[No Abstract] [Full Text] [Related]
40. Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial.
Amarenco P; Callahan A; Campese VM; Goldstein LB; Hennerici MG; Messig M; Sillesen H; Welch KM; Wilson DJ; Zivin JA
Stroke; 2014 Oct; 45(10):2974-82. PubMed ID: 25147328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
